Development of iPS-derived cell therapies for regenerative medicine, focusing on Parkinson's disease and liver disease.
C
CSR Analysis score
The organization is among the 50% most committed organizations, excluding the top 20%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: March 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
GenSight Biologics
B
Development of gene therapies for the treatment of blindness, focusing on mitochondrial targeting and optogenetics.
Poxel
A
Development of innovative treatments for chronic serious diseases with metabolic pathophysiology, focusing on non-alcoholic steatohepatitis (NASH) and rare disorders.
Priothera
B
Development of innovative therapies for hematological malignancies, focusing on immune modulators to enhance outcomes in allogeneic hematopoietic cell transplantation and CAR T cell therapy.
Initiatives identified among leaders
Développement d'indicateurs clés pour évaluer l'impact et les progrès RSE.
“Le groupe a développé et mis en œuvre des indicate...” - PoxelBilan carbone global
“Priothera développe des thérapies innovantes pour ...” - PriotheraStratégie RSE structurée autour de la santé, innovation et gestion responsable
“Poxel définit une stratégie RSE structurée autour ...” - Poxel48% of similar organizations communicate on CSR issues
+688 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports